# Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease

> **NCT06844565** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 110 (actual)

## Conditions studied

- Interleukin 12
- Interleukin 23
- Biomarker
- Diagnosis
- Crohn Disease

## Interventions

- **PROCEDURE:** Immunohistochemistry procedure

## Key facts

- **NCT ID:** NCT06844565
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06844565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06844565, "Role of IL 12 and IL 23 as Potential Biomarkers in Diagnosis of Early Crohn's Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06844565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*